The Integration Session podcast

The Antidistressant Effect: A New Lens on Psychedelics with Danica Johnson

0:00
32:28
Recuar 15 segundos
Avançar 15 segundos

Psychedelic treatments are often celebrated for their antidepressant potential, but emerging research suggests their effects go beyond traditional mood improvement. These compounds appear to work on multiple levels, prompting researchers to propose a more accurate term: “antidistressant.” 

But what exactly does “antidistressant” mean, and how might it better reflect the broad effects of psychedelics? What does this new lens mean for both research and clinical care?

In this episode, we’re joined by Danica Johnson, PhD candidate at the University of Toronto’s Institute of Medical Science and researcher at the Depression Centre Clinical Research Unit at Toronto Western Hospital. Co-supervised by Drs. Joshua Rosenblat and Roger McIntyre, Danica’s work sits at the forefront of psychedelic science. 

She breaks down what the term “antidistressant” really means and why it may be more accurate and useful than “antidepressant” when describing psychedelic treatment effects. 

We also discuss the multidimensional ways that psilocybin works, new findings about cognitive outcomes, ketamine’s real-world effectiveness in patients with comorbid PTSD, and the exciting research on the horizon in Toronto and beyond. 

More About Danica: Danica Johnson is a PhD Candidate at the University of Toronto’s Institute of Medical Science. She is co-supervised by Drs. Joshua Rosenblat and Roger McIntyre at the Depression Centre Clinical Research Unit at Toronto Western Hospital - University Health Network (UHN) in Toronto, Canada. Her research explores the effects of psychedelic compounds, particularly psilocybin and ketamine, on cognitive functioning in treatment-resistant unipolar and bipolar depression. She also investigates how trauma and psychiatric comorbidities influence treatment outcomes in these populations. Danica’s work has been recognized with several prestigious awards, including the Canadian Institutes of Health Research (CIHR) Canada Graduate Research Scholarship (CGRS-D), highlighting the quality and impact of her work in the realm of psychedelic research.

Mais episódios de "The Integration Session"